SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-004578
Filing Date
2022-06-28
Accepted
2022-06-28 15:30:22
Documents
13
Period of Report
2022-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_062822.htm   iXBRL 8-K 29916
5 EXHIBIT 10.1 exh_101.htm EX-10.1 89572
  Complete submission text file 0001171843-22-004578.txt   320206

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE apto-20220627.xsd EX-101.SCH 2953
3 XBRL LABEL FILE apto-20220627_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE apto-20220627_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_062822_htm.xml XML 3694
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 221049520
SIC: 2836 Biological Products, (No Diagnostic Substances)